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Conclusion:
Characterization of the risk of distant brain failure is important to treatment selection, prognosis and follow-up. Among lung cancer patients with brain metastases treated with SRS, our study found no impact from age, initial number/volume of metastases, EGFR/ALK status, or ECD status, on distant brain failure. However, this study did reveal a significantly shorter latency to appearance (DBMFS) of distant brain metastatic disease for patients with squamous vs. adenocarcinoma histology. The clinical prognostic significance of this histologic subtype-dependent difference on distant brain failure is the subject of further study.
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Prognostic value of minimal time to peak in dynamic 18F-FET-PET for high-grade glioma re-irradiation D.F. Fleischmann 
Material and Methods:
We retrospectively analyzed 72 patients suffering from recurrent high-grade glioma. Static and dynamic [18F]-FET-PET was performed prior to reirradiation. PET analysis revealed information about the maximal standardized uptake value (SUVmax) of the tumor corrected for the mean background (BG) (SUVmax/BG), the biologic tumor volume (BTV) and the mean tracer uptake within the BTV (SUVmean/BG). Dynamic parameters such as time-activity-curves (TACs) and minimal time-to-peak (TTPmin) were analyzed. Additional analysis was performed for gender, age, KPS, MGMT methylation status, IDH1 mutational status, WHO grading, concomitant bevacizumab therapy and the number of foci. The influence of PET derived and clinical parameters on post-recurrence survival (PRS) was investigated.
Results: TTPmin had a significant impact on PRS both on univariate (p= 0.027) and multivariate analysis (p= 0.008). Shorter TTPmin was related to shorter PRS after reirradiation with 6 months for TTPmin <12.5 min, 7 months for TTPmin 12.5 -25 min and 11 months for TTPmin >25 min (p= 0.027). Other factors significantly related to PRS were number of foci (p= 0.025), TAC classifications (p= 0.019; G1-2 vs G3-5), and gender (p=0.028).
Conclusion: Dynamic [18F]-FET-PET with
TTPmin is of high prognostic value for recurrent high-grade glioma and might help to personalize re-irradiation treatment regimens in future either through PET-guided dose escalation or by combination therapy with targeted agents. 
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